Manifold Bio Releases mBER-2 for AI Protein Design and Drug Delivery

Manifold Bio launched mBER-2, an AI protein design system for exploring in vivo biology at scale, with drug delivery as a key focus. The company positions it as a concrete path toward AI-driven disease cures.

2026-09-23 ~ 2026-09-23 · 2 related posts

• mBER-2: new AI protein design system targets in vivo drug delivery — AllThingsApx · 2026-09-23
• Manifold Bio unveils mBER-2, an AI protein design model tested in vivo — tomchapin · 2026-09-23